|
|
| Line 1: |
Line 1: |
| <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/960003/Cv/1'> | | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/960003/Cv/1'> |
| Tenofovir disoproxil, sold under the trade name Viread among others, is a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. See also [https://en.wikipedia.org/wiki/Tenofovir_disoproxil].
| | Efavirenz/emtricitabine/tenofovir, sold under the brand name Atripla among others, is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. It contains [[efavirenz]], [[emtricitabine]], and [[tenofovir disoproxil]]. It can be used by itself or together with other antiretroviral medications. |
| | |
| Tenofovir disoproxil is a prodrug that is quickly absorbed from the gut and cleaved to release tenofovir. Inside cells, tenofovir is phosphorylated to tenofovir diphosphate (which is analogous to a triphosphate, as tenofovir itself already has one phosphonate residue), the active compound that inhibits reverse transcriptase via chain termination.
| |
| | |
| <scene name='96/960003/Cv/3'>Tenofovir diphosphate (TNV) binding site</scene> at reverse transcriptase ([[3fkb]]). Water molecules are shown as red spheres.
| |
| | |
| <scene name='96/960003/Tnmbindingsite/5'>Tenofovir-monophosphate (TNM) binding site</scene> at reverse transcriptase ([[3fkb]]).
| |
|
| |
|
| </StructureSection> | | </StructureSection> |
| == References == | | == References == |
| <references/> | | <references/> |